Johnson Pharmacare Limited
BSE: JOHNPHARMA · Diversified Commercial Services
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Johnson Pharmacare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Johnson Pharmaceuticals Limited is an Indian public company engaged in the trading, distribution, and marketing of pharmaceutical formulations and medicinal products. The firm operates primarily within the domestic healthcare sector, focusing on the wholesale supply of drugs and medicines.
Business Model
The company generates revenue by sourcing pharmaceutical products and distributing them to meet domestic market demand. It functions as a middleman in the healthcare supply chain, leveraging its trading infrastructure to serve the Indian market.
Management Commentary
Management has focused on realigning the company's strategic direction to adapt to the evolving conditions of the Indian micro-cap pharmaceutical sector. Efforts are ongoing to maintain regulatory compliance while stabilising the firm's corporate identity.
Growth Outlook
Growth is contingent upon the company's ability to scale its wholesale operations and navigate the competitive landscape of the Indian pharmaceutical market. Future prospects remain tied to domestic healthcare demand and regulatory stability.
Key Risks
- Regulatory Compliance. The company faces significant risks related to the stringent and evolving regulatory framework governing the Indian pharmaceutical and distribution sector.
- Market Competition. As a small-scale player, the company faces intense competition from larger, more established pharmaceutical distributors with greater economies of scale.
- Liquidity and Volatility. Being a micro-cap entity, the company's stock may experience high volatility and limited liquidity, impacting investor sentiment.
- Supply Chain Dependency. The business model relies heavily on sourcing efficiency, making it vulnerable to disruptions in the supply chain or fluctuations in procurement costs.
Start your research today
Unlock AI insights, financials, peers and live data on Johnson Pharmacare Limited and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹0.53 Cr
TTM · standalone
RETURN ON EQUITY
0.9%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-3.2%
TTM · standalone
P/E
47.0x
Q1 FY26 · standalone
EV/EBITDA
73.9x
Q1 FY26 · standalone
EBITDA MARGIN
-50.6%
TTM · standalone
NET PROFIT MARGIN
15.8%
Q1 FY23 · standalone
DEBT TO EQUITY
0.0x
Q2 FY26 · standalone
Peers · Diversified Commercial Services
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Johnson Pharmacare LimitedJOHNPHARMA | ₹26 Cr | 47.00 | 73.47 | — | -50.6% | 0.9% | -3.2% | -39.0% |
Radiant Cash Management Services LimitedRADIANTCMS | ₹419 Cr | 13.36 | 7.12 | 1.8% | 12.5% | 10.0% | 14.0% | -34.1% |
Kalind LtdKALIND | ₹382 Cr | 0.18 | 8.31 | 29444.4% | 59.0% | 55.4% | 72.3% | -91.9% |
Majestic AutoMAJESAUT | ₹377 Cr | 3.85 | 4.85 | -45.0% | 167.0% | 15.7% | 18.6% | +4.9% |
Dev Accelerator LimitedDEVX | ₹340 Cr | 28.74 | 3.72 | — | 55.5% | 5.5% | 12.8% | — |
Mizzen VenturesMIZVEN | ₹94 Cr | 89.13 | 48.95 | — | 76.2% | 2.2% | 3.7% | -83.7% |
As of Q1 FY26
Financials
Johnson Pharmacare Limited
BSE: JOHNPHARMA · Diversified Commercial Services
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Johnson Pharmacare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Johnson Pharmaceuticals Limited is an Indian public company engaged in the trading, distribution, and marketing of pharmaceutical formulations and medicinal products. The firm operates primarily within the domestic healthcare sector, focusing on the wholesale supply of drugs and medicines.
Business Model
The company generates revenue by sourcing pharmaceutical products and distributing them to meet domestic market demand. It functions as a middleman in the healthcare supply chain, leveraging its trading infrastructure to serve the Indian market.
Management Commentary
Management has focused on realigning the company's strategic direction to adapt to the evolving conditions of the Indian micro-cap pharmaceutical sector. Efforts are ongoing to maintain regulatory compliance while stabilising the firm's corporate identity.
Growth Outlook
Growth is contingent upon the company's ability to scale its wholesale operations and navigate the competitive landscape of the Indian pharmaceutical market. Future prospects remain tied to domestic healthcare demand and regulatory stability.
Key Risks
- Regulatory Compliance. The company faces significant risks related to the stringent and evolving regulatory framework governing the Indian pharmaceutical and distribution sector.
- Market Competition. As a small-scale player, the company faces intense competition from larger, more established pharmaceutical distributors with greater economies of scale.
- Liquidity and Volatility. Being a micro-cap entity, the company's stock may experience high volatility and limited liquidity, impacting investor sentiment.
- Supply Chain Dependency. The business model relies heavily on sourcing efficiency, making it vulnerable to disruptions in the supply chain or fluctuations in procurement costs.
Start your research today
Unlock AI insights, financials, peers and live data on Johnson Pharmacare Limited and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹0.53 Cr
TTM · standalone
RETURN ON EQUITY
0.9%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-3.2%
TTM · standalone
P/E
47.0x
Q1 FY26 · standalone
EV/EBITDA
73.9x
Q1 FY26 · standalone
EBITDA MARGIN
-50.6%
TTM · standalone
NET PROFIT MARGIN
15.8%
Q1 FY23 · standalone
DEBT TO EQUITY
0.0x
Q2 FY26 · standalone
Peers · Diversified Commercial Services
As of Q1 FY26